methylprednisolone hemisuccinate has been researched along with Facial Palsy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Han, Y; Wang, H; Xu, L; Zhang, D | 1 |
| Fan, Z; Han, Y; Li, J; Liu, W; Mao, Y; Wang, H; Wang, M; Xu, L; Zhang, D | 1 |
| Akpolat, N; Alpay, HC; Gök, U; Kabakuş, N; Kilic, A; Yilmaz, B; Yoldaş, T | 1 |
3 other study(ies) available for methylprednisolone hemisuccinate and Facial Palsy
| Article | Year |
|---|---|
The alterations of matrix metalloproteinase-9 in mouse brainstem during herpes simplex virus type 1-induced facial palsy.
Topics: Animals; Brain Stem; Facial Paralysis; Herpesvirus 1, Human; Male; Matrix Metalloproteinase 9; Methylprednisolone Hemisuccinate; Mice; Mice, Inbred BALB C; Mifepristone; RNA, Messenger | 2013 |
Activation of NF-κB signaling pathway in HSV-1-induced mouse facial palsy: Possible relation to therapeutic effect of glucocorticoids.
Topics: Active Transport, Cell Nucleus; Animals; Anti-Inflammatory Agents; Brain Stem; Cyclooxygenase 2; Disease Models, Animal; Facial Paralysis; Glucocorticoids; Herpesvirus 1, Human; Hormone Antagonists; I-kappa B Kinase; Male; Methylprednisolone Hemisuccinate; Mice, Inbred BALB C; Mifepristone; NF-kappa B; Pyrrolidines; Receptors, Glucocorticoid; Signal Transduction; Thiocarbamates; Tumor Necrosis Factor-alpha | 2015 |
Comparisons of steroid, acyclovir, lipoprostoglandin E1 and steroid + acyclovir treatments in facial paralysis: a rat study.
Topics: Acyclovir; Alprostadil; Analysis of Variance; Animals; Anti-Inflammatory Agents; Bell Palsy; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Electrophysiology; Facial Nerve; Facial Paralysis; Female; Herpesvirus 1, Human; Incidence; Injections, Intramuscular; Injections, Intraperitoneal; Methylprednisolone Hemisuccinate; Prognosis; Rats; Treatment Outcome; Vasodilator Agents | 2005 |